QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.053496v1 307/1/314    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hu, M. Articles by Lin, H. Search for Related Content PubMed PubMed Citation Articles by Hu, M. Articles by Lin, H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Metabolism of Flavonoids via Enteric Recycling: Mechanistic Studies of Disposition of Apigenin in the Caco-2 Cell Culture Model

Department of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Pullman, Washington

The purpose of this study was to determine the mechanisms responsible for intestinal disposition of apigenin in the human Caco-2 cell culture model. The results indicated that most of the absorbed apigenin (10 µM) were conjugated and only a small fraction was transported intact. The amounts of conjugates excreted, especially that of the sulfate, were dependent on days-post-seeding. Apical efflux of apigenin sulfate did not change with concentration of apigenin (4 to 40 µM), whereas its basolateral efflux increased (p < 0.01) with concentration and plateaued at about 25 µM. In contrast, sulfate formation rates in cell lysate increased with concentration and plateaued at 25 µM and were 4 to 6 times faster than the corresponding excretion rates. Formation and polarized excretion rates of glucuronidated apigenin increased with apigenin concentration but formation rates were usually 2.5 to 6 times faster than the corresponding excretion rates. Inhibitors of multidrug resistance-related proteins (MRPs) such as leukotriene C₄ and MK-571, which inhibited glucuronidation of apigenin at a high concentration (25 µM), significantly decreased excretion of both apigenin conjugates, and higher concentrations of MK-571 increased the extent of inhibition. In contrast, an organic anion transporter (OAT) inhibitor estrone sulfate only inhibited excretion of apigenin sulfate. In conclusion, we have shown for the first time that intestinal efflux is the rate-limiting step in the intestinal excretion of phase II conjugates of flavones. Furthermore, MRP and OAT are involved in the intestinal efflux of these hydrophilic phase II conjugates.

Address correspondence to: Dr. Ming Hu, College of Pharmacy, Washington State University, Pullman, WA 99164-6510. E-mail: minghu{at}wsu.edu

This article has been cited by other articles:

				S. W. J. Wang, K. H. Kulkarni, L. Tang, J. R. Wang, T. Yin, T. Daidoji, H. Yokota, and M. Hu Disposition of Flavonoids via Enteric Recycling: UDP-Glucuronosyltransferase (UGT) 1As Deficiency in Gunn Rats Is Compensated by Increases in UGT2Bs Activities J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 1023 - 1031. [Abstract] [Full Text] [PDF]

				H. R. Kim, R. Rajaiah, Q.-L. Wu, S. R. Satpute, M. T. Tan, J. E. Simon, B. M. Berman, and K. D. Moudgil Green Tea Protects Rats against Autoimmune Arthritis by Modulating Disease-Related Immune Events J. Nutr., November 1, 2008; 138(11): 2111 - 2116. [Abstract] [Full Text] [PDF]

				W. Brand, P. A. I. van der Wel, M. J. Rein, D. Barron, G. Williamson, P. J. van Bladeren, and I. M. C. M. Rietjens Metabolism and Transport of the Citrus Flavonoid Hesperetin in Caco-2 Cell Monolayers Drug Metab. Dispos., September 1, 2008; 36(9): 1794 - 1802. [Abstract] [Full Text] [PDF]

				S. W. J. Wang, J. Chen, X. Jia, V. H. Tam, and M. Hu Disposition of Flavonoids via Enteric Recycling: Structural Effects and Lack of Correlations between in Vitro and in Situ Metabolic Properties Drug Metab. Dispos., November 1, 2006; 34(11): 1837 - 1848. [Abstract] [Full Text] [PDF]

				X. Wen and T. Walle Methylated Flavonoids Have Greatly Improved Intestinal Absorption and Metabolic Stability Drug Metab. Dispos., October 1, 2006; 34(10): 1786 - 1792. [Abstract] [Full Text] [PDF]

				F. Xu, Y. Zhang, S. Xiao, X. Lu, D. Yang, X. Yang, C. Li, M. Shang, P. Tu, and S. Cai ABSORPTION AND METABOLISM OF ASTRAGALI RADIX DECOCTION: IN SILICO, IN VITRO, AND A CASE STUDY IN VIVO Drug Metab. Dispos., June 1, 2006; 34(6): 913 - 924. [Abstract] [Full Text] [PDF]

				J. Chen, S. Wang, X. Jia, S. Bajimaya, H. Lin, V. H. Tam, and M. Hu DISPOSITION OF FLAVONOIDS VIA RECYCLING: COMPARISON OF INTESTINAL VERSUS HEPATIC DISPOSITION Drug Metab. Dispos., December 1, 2005; 33(12): 1777 - 1784. [Abstract] [Full Text] [PDF]

				E. J. Jeong, Y. Liu, H. Lin, and M. Hu SPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10 Drug Metab. Dispos., June 1, 2005; 33(6): 785 - 794. [Abstract] [Full Text] [PDF]

				X. Jia, J. Chen, H. Lin, and M. Hu Disposition of Flavonoids via Enteric Recycling: Enzyme-Transporter Coupling Affects Metabolism of Biochanin A and Formononetin and Excretion of Their Phase II Conjugates J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1103 - 1113. [Abstract] [Full Text] [PDF]

				E. J. Jeong, H. Lin, and M. Hu Disposition Mechanisms of Raloxifene in the Human Intestinal Caco-2 Model J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 376 - 385. [Abstract] [Full Text] [PDF]